Medipron Certified as a 'Technology Evaluation Guaranteed Venture Company'

[Asia Economy Reporter Hyunseok Yoo] Mediphrondivity, an innovative new drug development company, announced on the 17th that it has obtained venture business certification.

Venture business certification is granted to companies recognized by the government as having high technological capability or growth potential and deemed necessary to support as leading enterprises.

Among the three criteria under the "Special Measures for the Promotion of Venture Businesses Act"?venture investment companies, research and development companies, and technology evaluation guarantee companies?a company must meet at least one. Mediphron was certified as a technology evaluation guarantee company, recognizing the excellence of its technology.

CEO Nogiseon of Mediphron stated, "The topical non-narcotic analgesic, which received IND approval for Phase 1 clinical trials from the Ministry of Food and Drug Safety last June, is currently under consultation with related agencies to commence clinical trials within this year. The 'early diagnosis auxiliary medical device for Alzheimer's disease,' developed jointly with Quantametrics, is awaiting product approval from the Ministry of Food and Drug Safety and will be developed as the company's future cash cow."

This content was produced with the assistance of AI translation services.